by Garth Sundem | Jun 17, 2019 | Featured, Latest News, Patient Care
Jennifer Diamond, MD OnKure, Inc. and the University of Colorado Cancer Center announced enrollment of the first patient in a first-in-human phase 1 clinical trial testing investigational anti-cancer agent OKI-179, a novel and Class-selective HDAC inhibitor, in...
by Taylor Abarca | Jun 4, 2019 | Featured, Patient Care
For most people finding out that they have prostate cancer multiple times in the span of just a few years seem like a cruel joke. But Jonathan Ormes is not most people. After being told for the third time that he had the disease he decided to take a chance on a...
by Taylor Abarca | Jun 2, 2019 | Featured, Latest News, Patient Care
Johnna Vinson, after treatment Johnna Vinson knew something was very wrong, but she couldn’t seem to get an answer even after months of testing. In July of 2017 she found herself in the emergency room with the words “another 24 hours and you probably wouldn’t be here”...
by Garth Sundem | May 21, 2019 | Featured, Latest News, Patient Care
D. Ross Camidge, MD, PhD Brigatinib is a next-generation ALK inhibitor that earned FDA approval in 2017 as a second-line therapy after treatment with crizotinib for ALK-positive non-small cell lung cancer. Recently, clinical trial results published in the New England...
by Taylor Abarca | Apr 29, 2019 | Featured, Latest News, Patient Care
When you or someone you love is diagnosed with cancer, the days or weeks following can be overwhelming. Often, patients have to travel to different doctors at different locations for scans and other tests before a care team can recommend the best treatment plan. At...
by CU Cancer Center | Apr 24, 2019 | Latest News, Patient Care
What is esophageal cancer? Esophageal cancer is cancer that arises in the esophagus – a hollow, muscular tube that is about a foot long. It helps pass food and liquids from the back of the mouth to the stomach. The esophagus lies just behind the trachea and in front...
